IGM’s autoimmune pivot backfires as top drug disappoints in testing
The biotech will stop developing two drugs and lay off nearly three-quarters of its staff after its lead therapy wasn’t as ...
IGM Biosciences Stock: Bad News With No Turnaround In Sight
IGM Biosciences has halted all oncology programs and faces a significant pipeline upheaval. Read why I maintain my Sell ...
IGM Biosciences Halts Antibody Therapies, Cuts Workforce
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
IGM to slash 73% of workforce, halt two drug programs
IGM Biosciences (IGMS) is slashing its workforce by 73% and discontinuing development of two of its lead drug candidates in ...
IGM Biosciences Shares Drop 68% as Company Halts Key Programs and Cuts Workforce
The company is reducing its workforce by 73% and evaluating strategic alternatives to preserve shareholder value.
Nature5y
Major diagnostic markers for dengue infection
IgM and IgG antibodies against the dengue virus can be detected in most patients five days after the onset of symptoms. IgG can be measured for many months and even years after a dengue infection.